HRGN (Harvard Apparatus Regenerative Technology) Moat Score: 3/10 (As of Jul. 11, 2026)


HRGN Harvard Apparatus Regenerative Technology Inc HRGN
27 GF Score
Price $1.05
GF Value $5.34
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Harvard Apparatus Regenerative Technology Moat Score?

Harvard Apparatus Regenerative Technology HRGN 27 Moat Score is 3 as of Jul. 11, 2026. GuruFocus rates HRGN with a GF Score™ of 27/100 and a GF Value™ of $5.34 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 2,053 Consumer Packaged Goods companies, Harvard Apparatus Regenerative Technology ranks better than 91.09% on this metric.

Harvard Apparatus Regenerative Technology has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

Harvard Apparatus Regenerative Technology has No Moat: Harvard Apparatus Regenerative Technology Inc has a very weak moat due to limited market share and customer loyalty in the regenerative medicine field. The industry is competitive with rapid innovation cycles.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Harvard Apparatus Regenerative Technology might have No Moat - Very weak/transient advantages.

Harvard Apparatus Regenerative Technology  (OTCPK:HRGN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Harvard Apparatus Regenerative Technology Moat Score Related Terms

HRGN vs DTEAF, STCB, JVA: Moat Score Comparison

For the Packaged Foods subindustry, Harvard Apparatus Regenerative Technology's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harvard Apparatus Regenerative Technology Moat Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Harvard Apparatus Regenerative Technology's Moat Score distribution charts can be found below:

* The bar in red indicates where Harvard Apparatus Regenerative Technology's Moat Score falls into.


HRGN
27GF Score
Harvard Apparatus Regenerative Technology Inc HRGN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
Harvard Apparatus Regenerative Technology (HRGN) has a Moat Score of 3 as of Jul. 11, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Harvard Apparatus Regenerative Technology ranks #183 out of 2053 companies in the Consumer Packaged Goods industry, placing it in the top 8.9%.
Is Harvard Apparatus Regenerative Technology's Moat Score too high?
Harvard Apparatus Regenerative Technology's current Moat Score is 3. Based on the distribution chart, Harvard Apparatus Regenerative Technology ranks #183 out of 2053 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Harvard Apparatus Regenerative Technology has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Harvard Apparatus Regenerative Technology's Moat Score compare to DTEAF and STCB?
According to the Consumer Packaged Goods industry distribution chart, Harvard Apparatus Regenerative Technology ranks #183 out of 2053 companies for Moat Score. This places Harvard Apparatus Regenerative Technology in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Consumer Packaged Goods company?
A good Moat Score depends on the Consumer Packaged Goods industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Harvard Apparatus Regenerative Technology's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harvard Apparatus Regenerative Technology stock overvalued right now?
Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology (HRGN) is currently considered Possible Value Trap. The stock's GF Value™ is $5.34, compared to a current price of $1.05 — trading 80.3% below its estimated fair value. The current Moat Score is 3. Harvard Apparatus Regenerative Technology's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Harvard Apparatus Regenerative Technology (HRGN), the current Moat Score is 3 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harvard Apparatus Regenerative Technology (HRGN) Overvalued in 2026?

Based on GuruFocus' analysis, Harvard Apparatus Regenerative Technology stock appears to be undervalued. The current stock price of $1.05 is trading 80.3% below its estimated GF Value™ of $5.34. GuruFocus considers Harvard Apparatus Regenerative Technology to be Possible Value Trap.

Key valuation signals for HRGN:

  • Moat Score: 3
  • GF Value™: $5.34 vs. price of $1.05 (80.3% below fair value)
  • GF Score™: 27/100 with 2 warning signs

No single metric tells the full story. See the HRGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Harvard Apparatus Regenerative Technology Business Description

Address 84 October Hill Road, Suite 11, Holliston, MA, USA, 01746
Harvard Apparatus Regenerative Technology is a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the gastrointestinal system and other organs that result from cancer, trauma, or birth defects. Its technology is based on a proprietary cell-therapy platform that uses a patient's own stem cells to regenerate and restore function to damaged organs. The Company has two operating and reportable segments: Regenerative Biotech, focused on the development of regenerative medicine treatments with operations currently in the United States, and Consumer Health Products relating to consumer health products with operations currently in Asia.
27GF Score

Get the complete analysis for HRGN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.05
Price
$5.34
GF Value